peginterferon
Jump to navigation
Jump to search
Introduction
Attachment of a polyethylene glycol moeity to interferon-2 alpha or interferon-2 beta results in a longer half-life of the protein.
Contraindications
- avoid in patients with depression
Laboratory
- IFNL3 variation rs12979860 predicts response to PEG-interferon-alpha
More general terms
More specific terms
References
- ↑ Journal Watch 21(2):14, 2001
- ↑ Department of Veterans Affairs, VA National Formulary
- ↑ Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline information for boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir and IFNL3. https://www.pharmgkb.org/guideline/PA166110235